Careful patient stratification and sex-aware trial designs would be essential for evaluating such applications
Its not marketed as a sexual-health product, a hormone therapy, or a stimulant-based energy shot
In educational frameworks, DSIP is positioned at most for the patient with documented, persistent sleep-architecture problems who has genuinely failed sleep hygiene, CBT-I, and melatonin, and who explicitly understands they would be engaging with something investigational rather than a validated treatment
The standard CJC-1295 no DAC amount in research contexts is 100200 mcg per administration, 13 times daily , administered in a fasted state
We can't pretend that is a sustainable solution, especially in a world where peptides are part of the future of medicine